KLK3 and metastatic prostate carcinoma: What are the associations among race and ethnicity, competing mortality risk, and prostate-specific antigen (PSA) history with respect to prostate cancer–specific mortality (PCSM) and metastatic prostate cancer (mPCa) among screened men after age 70 years?